Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

529.82
-0.5300-0.10%
Volume:318.97K
Turnover:168.72M
Market Cap:23.22B
PE:19.02
High:533.73
Open:528.36
Low:524.30
Close:530.35
52wk High:548.12
52wk Low:266.98
Shares:43.83M
Float Shares:41.99M
Volume Ratio:0.74
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.86
EPS(LYR):27.86
ROE:19.71%
ROA:12.42%
PB:3.27
PE(LYR):19.02

Loading ...

United Therapeutics Corp - Ralinepag Treatment Well-Tolerated With Consistent Safety Profile

THOMSON REUTERS
·
Mar 02

United Therapeutics Corp - Nda for Ralinepag to Be Submitted to FDA by H2 2026

THOMSON REUTERS
·
Mar 02

United Therapeutics Corp - Phase 3 Study of Ralinepag Meets Primary Endpoint, 47% Clinical Improvement

THOMSON REUTERS
·
Mar 02

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy

THOMSON REUTERS
·
Mar 02

United Therapeutics Earnings Call Signals Growth Ahead

TIPRANKS
·
Mar 01

These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings

Benzinga
·
Feb 27

Stock Track | United Therapeutics Plummets 7.19% Intraday on Tyvaso Revenue Miss

Stock Track
·
Feb 27

United Therapeutics' Soft-Mist Inhaler for Tyvaso Could Boost Market Share, RBC Says

MT Newswires Live
·
Feb 27

United Therapeutics Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Feb 27

RBC Raises Price Target on United Therapeutics to $643 From $587, Keeps Outperform Rating

MT Newswires Live
·
Feb 26

U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite

Reuters
·
Feb 26

United Therapeutics Corp : Jefferies Raises Target Price to $640 From $575

THOMSON REUTERS
·
Feb 26

United Therapeutics price target raised to $466 from $423 at Wells Fargo

TIPRANKS
·
Feb 26

Balancing Franchise Headwinds and Pipeline Upside: Rationale Behind a Hold on United Therapeutics

TIPRANKS
·
Feb 26

United Therapeutics Director Christopher Causey Disposes of Common Shares

Reuters
·
Feb 26

United Therapeutics price target raised to $569 from $546 at BofA

TIPRANKS
·
Feb 26

RBC says United Therapeutics TreSMI presents ‘material risk’ to MannKind

TIPRANKS
·
Feb 26

United Therapeutics Gains on Development of New Inhaler, 4Q Net Income Beat

Dow Jones
·
Feb 26

Leerink sees MannKind selloff as ‘overreaction’ to headline news

TIPRANKS
·
Feb 26

Liquidia reaction on United Therapeutics’ TreSMI reveal ‘overdone,’ says Needham

TIPRANKS
·
Feb 26